499 related articles for article (PubMed ID: 7493346)
1. Targeting of liver metastases of colorectal cancer with IgG, F(ab')2, and Fab' anti-carcinoembryonic antigen antibodies labeled with 99mTc: the role of metabolism and kinetics.
Behr T; Becker W; Hannappel E; Goldenberg DM; Wolf F
Cancer Res; 1995 Dec; 55(23 Suppl):5777s-5785s. PubMed ID: 7493346
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy and tumor-targeting kinetics of complete versus fragmented 99mTc-labeled anti-carcinoembryonic antigen antibodies: an intraindividual comparison.
Behr TM; Becker WS; Klein MW; Bair HJ; Scheele JR; Wolf FG
Cancer Res; 1995 Dec; 55(23 Suppl):5786s-5793s. PubMed ID: 7493347
[TBL] [Abstract][Full Text] [Related]
3. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
[TBL] [Abstract][Full Text] [Related]
4. Comparative tumor localization of whole immunoglobulin G anticarcinoembryonic antigen monoclonal antibodies IMMU-4 and IMMU-4 F(ab')2 in colorectal cancer patients.
Murray JL; Rosenblum MG; Zhang HZ; Podoloff DA; Kasi LP; Curley SA; Chan JC; Roh M; Hohn DC; Brewer H
Cancer; 1994 Feb; 73(3 Suppl):850-7. PubMed ID: 8306270
[TBL] [Abstract][Full Text] [Related]
5. Comparison of complete versus fragmented technetium-99m-labeled anti-CEA monoclonal antibodies for immunoscintigraphy in colorectal cancer.
Behr TM; Becker WS; Bair HJ; Klein MW; Stühler CM; Cidlinsky KP; Wittekind CW; Scheele JR; Wolf FG
J Nucl Med; 1995 Mar; 36(3):430-41. PubMed ID: 7884505
[TBL] [Abstract][Full Text] [Related]
6. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
Goldenberg DM; Goldenberg H; Sharkey RM; Higginbotham-Ford E; Lee RE; Swayne LC; Burger KA; Tsai D; Horowitz JA; Hall TC
Cancer Res; 1990 Feb; 50(3 Suppl):909s-921s. PubMed ID: 2297741
[TBL] [Abstract][Full Text] [Related]
7. Pretargeting for cancer radioimmunotherapy with bispecific antibodies: role of the bispecific antibody's valency for the tumor target antigen.
Karacay H; Sharkey RM; McBride WJ; Griffiths GL; Qu Z; Chang K; Hansen HJ; Goldenberg DM
Bioconjug Chem; 2002; 13(5):1054-70. PubMed ID: 12236788
[TBL] [Abstract][Full Text] [Related]
8. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibody CEA 102: whole IgG versus F(ab')2 fragments].
Wada K; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Sakuma S; Takagi H
Nihon Geka Gakkai Zasshi; 1992 Mar; 93(3):266-73. PubMed ID: 1513308
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunodetection of colorectal carcinoma using technetium-99m-labeled Fab' fragments of the IMMU-4 anti-carcinoembryonic antigen monoclonal antibody.
Moffat FL; Vargas-Cuba RD; Serafini AN; Casillas VJ; Morillo G; Benedetto P; Robinson DS; Ardalan B; Manten HD; Clark KC
Cancer; 1994 Feb; 73(3 Suppl):836-45. PubMed ID: 8306268
[TBL] [Abstract][Full Text] [Related]
10. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
Temponi M; Gold AM; Ferrone S
Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670
[TBL] [Abstract][Full Text] [Related]
11. Metastatic colorectal cancer: radioimmunoscintigraphy with a stabilized In-111-labeled F(ab')2 fragment of an anti-CEA monoclonal antibody.
Lamki LM; Patt YZ; Rosenblum MG; Shanken LJ; Thompson LB; Schweighardt SA; Frincke JM; Murray JL
Radiology; 1990 Jan; 174(1):147-51. PubMed ID: 2294542
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution of radiolabeled monoclonal antibody E48 IgG and F(ab')2 in patients with head and neck cancer.
de Bree R; Roos JC; Quak JJ; den Hollander W; Wilhelm AJ; van Lingen A; Snow GB; Dongen GA
Clin Cancer Res; 1995 Mar; 1(3):277-86. PubMed ID: 9815983
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.
Holton OD; Black CD; Parker RJ; Covell DG; Barbet J; Sieber SM; Talley MJ; Weinstein JN
J Immunol; 1987 Nov; 139(9):3041-9. PubMed ID: 3499463
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of monoclonal immunoglobulin G1, F(ab')2, and Fab' in mice.
Covell DG; Barbet J; Holton OD; Black CD; Parker RJ; Weinstein JN
Cancer Res; 1986 Aug; 46(8):3969-78. PubMed ID: 3731067
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W
Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961
[TBL] [Abstract][Full Text] [Related]
16. Optimization of IGF-1R SPECT/CT imaging using 111In-labeled F(ab')2 and Fab fragments of the monoclonal antibody R1507.
Heskamp S; van Laarhoven HW; Molkenboer-Kuenen JD; Bouwman WH; van der Graaf WT; Oyen WJ; Boerman OC
Mol Pharm; 2012 Aug; 9(8):2314-21. PubMed ID: 22747077
[TBL] [Abstract][Full Text] [Related]
17. Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens.
Sharkey RM; Gold DV; Aninipot R; Vagg R; Ballance C; Newman ES; Ostella F; Hansen HJ; Goldenberg DM
Cancer Res; 1990 Feb; 50(3 Suppl):828s-834s. PubMed ID: 2297729
[TBL] [Abstract][Full Text] [Related]
18. Reduction of renal uptake of monoclonal antibody fragments by amino acid infusion.
Behr TM; Becker WS; Sharkey RM; Juweid ME; Dunn RM; Bair HJ; Wolf FG; Goldenberg DM
J Nucl Med; 1996 May; 37(5):829-33. PubMed ID: 8965154
[TBL] [Abstract][Full Text] [Related]
19. Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.
Delaloye B; Bischof-Delaloye A; Buchegger F; von Fliedner V; Grob JP; Volant JC; Pettavel J; Mach JP
J Clin Invest; 1986 Jan; 77(1):301-11. PubMed ID: 3484753
[TBL] [Abstract][Full Text] [Related]
20. Targeting osteomyelitis with complete [99mTc]besilesomab and fragmented [99mTc]sulesomab antibodies: kinetic evaluations.
Gratz S; Reize P; Kemke B; Kampen WU; Luster M; Höffken H
Q J Nucl Med Mol Imaging; 2016 Dec; 60(4):413-23. PubMed ID: 25325395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
